Clinical Trials Browser

OTHER × Melanoma × Muromonab-CD3 × Clear all

NCT00004022 2013-04-05

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Completed

Melanoma